Fortrea
Magdalena Reiter is a seasoned professional in clinical research, currently serving as a Senior Clinical Research Associate 2 at Fortrea since November 2021, with prior experience at IQVIA in various roles, including Senior Clinical Research Associate 2 and Senior Clinical Research Associate 1. Magdalena's background includes a role as a Clinical Research Associate 2 at PPD and Clinical Research Associate 1 at IQVIA, focusing on phase III trials in therapeutic areas such as dermatology, diabetes type 1, pulmonary hypertension, and axial spondyloarthritis. Magdalena also contributed to the global study training management team at Eli Lilly and Company as a Study-related Training Assistant and engaged in academic research during a Master Thesis at St. Anna Kinderkrebsforschung. Educationally, Magdalena holds a Master of Science in Molecular Biotechnology and a Bachelor of Science in Molecular Biotechnology from FH Campus Wien.
This person is not in any teams
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.